Timur Artemev

At P42 we strive to discover innovations that make the future a better place for everyone – the new tomorrow! Exciting projects are born out of big thinking by starting small. Project42 provides exclusive access to products that answer life’s newest challenges. We are on a constant quest for new product solutions that change the world for the better. P42 Hardware Incubator As a technology incubator, we are always on the lookout for the best talent in the market place combined with the brightest ideas. If you want to be part of an innovative and cutting-edge business who are at the forefront of creating disruptive technology then please get in touch with us for a confidential conversation.

Retrotope‘s proprietary drug platform represents a breakthrough in the treatment of degenerative diseases. Research has established a link between the oxidative damage of lipids in mitochondrial membranes and neurodegeneration in Parkinson’s, Alzheimer’s, Friedreich’s ataxia and other diseases. Retrotope’s first drug candidate, RT001, confers cell protection against oxidative stress in high energy tissues like brain, retina and heart tissue by inhibiting mitochondrial lipid peroxidation. Its mechanism of action has been shown not only to prevent further cellular damage but also to recover mitochondrial function. RT001’s molecular structure is so similar to ordinary fats that the body naturally distributes them throughout the tissues wherever they are needed. The drug has been determined safe in human trials in a recent Phase 1/2 clinical trial in Friedreich’s ataxia patients. Retrotope is a privately held company founded and backed by world—renowned scientists, entrepreneurs, and investors. The company founders have dozens of years of experience in drug discovery technologies, a member of the US National Academy of Sciences, and several successful startups among them. Retrotope has developed its science virtually, with over 50 collaborations at major centers of excellence around the world that have yielded insights into the mechanisms of several diseases.

At P42 we strive to discover innovations that make the future a better place for everyone – the new tomorrow! Exciting projects are born out of big thinking by starting small. Project42 provides exclusive access to products that answer life’s newest challenges. We are on a constant quest for new product solutions that change the world for the better. P42 Hardware Incubator As a technology incubator, we are always on the lookout for the best talent in the market place combined with the brightest ideas. If you want to be part of an innovative and cutting-edge business who are at the forefront of creating disruptive technology then please get in touch with us for a confidential conversation.

«Сеть Связной» - крупнейшая российская компания, работающая на рынке сотового ритейла. Основными направлениями деятельности компании являются осуществление розничной торговли сотовыми телефонами, портативной техникой, аксессуарами и иными товарами, а также подключение абонентов к операторам связи. В салонах компании представлены не только технические новинки рынка мобильной электроники, но и широкий выбор дополнительных услуг. Сегодня, в «Евросети» можно приобрести и оплатить авиабилеты, туристические путёвки, билеты на развлекательные и спортивные мероприятия, оформить полисы негосударственных пенсионных фондов, оплатить штраф ГИБДД, внести абонентские платежи за спутниковое телевидение, платежи по кредитам, настроить сотовый телефон и многое другое. В настоящее время компания управляет более 4000 салонами в России и Республике Беларусь. Доля компании на российском рынке сотовых телефонов составляет более 30% по итогам 3 квартала 2011 года. Компания «Евросеть» является крупнейшей непродовольственной сетью России по показателям рентабельности, EBITDA и норме чистой прибыли за 2010 год по версии «Best Retail - 2010», лидером профессионального рейтинга «Репутация - 2010» и обладателем премии «Абсолютный бренд 2011».